Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kees Brinkman

Showing results (81-90 of 99) with videos related to

Pageof 10
Sort By:
Open Forum Infectious Diseases|February 3, 2016
The Effect of Rosuvastatin on Markers of Immune Activation in Treatment-Naive Human Immunodeficiency Virus-PatientsRobyn G M Weijma, Eric R A Vos, Jaap Ten Oever, et al.
The Journal of Infectious Diseases|June 16, 2007
Increase in HCV incidence among men who have sex with men in Amsterdam most likely caused by sexual transmissionThijs J W van de Laar, Akke K van der Bij, Maria Prins, et al.
Plos One|July 25, 2015
Maraviroc Intensification of cART in Patients with Suboptimal Immunological Recovery: A 48-Week, Placebo-Controlled Randomized TrialSteven F L van Lelyveld, Julia Drylewicz, Maaike Krikke, et al.
Viruses|April 27, 2024
Cardiometabolic Differences in People Living with HIV Receiving Integrase Strand Transfer Inhibitors Compared to Non-nucleoside Reverse Transcriptase Inhibitors: Implications for Current ART StrategiesWilhelm A J W Vos, Nadira Vadaq, Vasiliki Matzaraki, et al.
The Lancet. HIV|December 28, 2020
HCV micro-elimination in individuals with HIV in the Netherlands 4 years after universal access to direct-acting antivirals: a retrospective cohort studyColette Smit, Anders Boyd, Bart J A Rijnders, et al.
Eclinicalmedicine|January 1, 2020
Immune reconstitution inflammatory syndrome in HIV infected late presenters starting integrase inhibitor containing antiretroviral therapyIngeborg E A Wijting, Ferdinand W N M Wit, Casper Rokx, et al.
AIDS (London, England)|May 24, 2024
Immunogenicity of a bivalent BA.1 COVID-19 booster vaccine in people with HIV in the NetherlandsMarlou J Jongkees, Ngoc H Tan, Daryl Geers, et al.
BMJ Open|November 14, 2023
What is the aetiology of dysnatraemia in COVID-19 and how is this related to outcomes in patients admitted during earlier and later COVID-19 waves? A multicentre, retrospective observational study in 11 Dutch hospitalsLianne de Haan, Marije Ten Wolde, Martijn Beudel, et al.
BMJ Open|December 9, 2023
Does atrial fibrillation affect prognosis in hospitalised COVID-19 patients? A multicentre historical cohort study in the NetherlandsJocelyn R Spruit, René W M M Jansen, Joris R de Groot, et al.
BMJ Open|November 22, 2024
Booster-free anti-retroviral therapy for persons living with HIV and multidrug resistance (B-Free): protocol for a multicentre, multistage, randomised, controlled, non-inferiority trialMarie Ballif, Dominique Braun, Alexandra Calmy, et al.
Pageof 10

Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
Open Forum Infectious Diseases|February 3, 2016
The Effect of Rosuvastatin on Markers of Immune Activation in Treatment-Naive Human Immunodeficiency Virus-PatientsRobyn G M Weijma, Eric R A Vos, Jaap Ten Oever, et al.
The Journal of Infectious Diseases|June 16, 2007
Increase in HCV incidence among men who have sex with men in Amsterdam most likely caused by sexual transmissionThijs J W van de Laar, Akke K van der Bij, Maria Prins, et al.
Plos One|July 25, 2015
Maraviroc Intensification of cART in Patients with Suboptimal Immunological Recovery: A 48-Week, Placebo-Controlled Randomized TrialSteven F L van Lelyveld, Julia Drylewicz, Maaike Krikke, et al.
Viruses|April 27, 2024
Cardiometabolic Differences in People Living with HIV Receiving Integrase Strand Transfer Inhibitors Compared to Non-nucleoside Reverse Transcriptase Inhibitors: Implications for Current ART StrategiesWilhelm A J W Vos, Nadira Vadaq, Vasiliki Matzaraki, et al.
The Lancet. HIV|December 28, 2020
HCV micro-elimination in individuals with HIV in the Netherlands 4 years after universal access to direct-acting antivirals: a retrospective cohort studyColette Smit, Anders Boyd, Bart J A Rijnders, et al.
Eclinicalmedicine|January 1, 2020
Immune reconstitution inflammatory syndrome in HIV infected late presenters starting integrase inhibitor containing antiretroviral therapyIngeborg E A Wijting, Ferdinand W N M Wit, Casper Rokx, et al.
AIDS (London, England)|May 24, 2024
Immunogenicity of a bivalent BA.1 COVID-19 booster vaccine in people with HIV in the NetherlandsMarlou J Jongkees, Ngoc H Tan, Daryl Geers, et al.
BMJ Open|November 14, 2023
What is the aetiology of dysnatraemia in COVID-19 and how is this related to outcomes in patients admitted during earlier and later COVID-19 waves? A multicentre, retrospective observational study in 11 Dutch hospitalsLianne de Haan, Marije Ten Wolde, Martijn Beudel, et al.
BMJ Open|December 9, 2023
Does atrial fibrillation affect prognosis in hospitalised COVID-19 patients? A multicentre historical cohort study in the NetherlandsJocelyn R Spruit, René W M M Jansen, Joris R de Groot, et al.
BMJ Open|November 22, 2024
Booster-free anti-retroviral therapy for persons living with HIV and multidrug resistance (B-Free): protocol for a multicentre, multistage, randomised, controlled, non-inferiority trialMarie Ballif, Dominique Braun, Alexandra Calmy, et al.
Pageof 10